• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清软骨寡聚基质蛋白作为预测膝关节骨关节炎发生和进展的生物标志物。

Serum cartilage oligomeric matrix protein as a biomarker for predicting development and progression of knee osteoarthritis.

机构信息

Department of Orthopaedics and Trauma, Afe Babalola University Multi-System Hospital, Ado-Ekiti, Ekiti State, Nigeria.

Accidents and Emergency Unit, ABUAD Multi-System Hospital, Ado-Ekiti, Ekiti State, Nigeria.

出版信息

Int Orthop. 2021 Mar;45(3):551-557. doi: 10.1007/s00264-021-04943-4. Epub 2021 Jan 12.

DOI:10.1007/s00264-021-04943-4
PMID:33438071
Abstract

PURPOSE

Current modes of diagnosing and monitoring knee osteoarthritis (OA) are based on weight bearing radiographs usually made by the time joint destruction is already established. Cartilage oligomeric matrix protein (COMP) is a breakdown product of cartilage and its serum levels may be a potential indicator of early destruction in OA. This study aimed to ascertain the usefulness of serum COMP (sCOMP) in diagnosis and monitoring of knee joint OA within the study environment.

METHODS

Ninety consenting adults were recruited. In the control group, 45 subjects having a diagnosis of knee OA had clinical and radiological grading done and blood samples taken for assay of sCOMP using the sandwich ELISA method. Forty-five volunteers with no features of osteoarthritis also had serum collected for sCOMP assay. Values obtained were then cross referenced with demographic indices, clinical and radiological severity grade to assess for relationships.

RESULTS

Serum COMP was found to be significantly elevated (p = 0.0001) in the study group. The mean values and standard deviation of sCOMP were 3400 ± 1042.9 ng/ml and 2222 ± 605.6 ng/ml for the study and control groups, respectively. Higher values of sCOMP were found to be associated with higher clinical and radiological grades of OA.

CONCLUSION

The study demonstrates that sCOMP is significantly higher in patients with knee OA than in those without the disease. Values of sCOMP were also found to increase with severity of knee OA, indicating the possibility of its use as a marker of diagnosis and severity.

摘要

目的

目前诊断和监测膝骨关节炎(OA)的模式基于负重 X 射线,通常在关节破坏已经确立时进行。软骨寡聚基质蛋白(COMP)是软骨的降解产物,其血清水平可能是 OA 早期破坏的潜在指标。本研究旨在确定血清 COMP(sCOMP)在研究环境中诊断和监测膝关节 OA 的有用性。

方法

招募了 90 名同意的成年人。在对照组中,45 名诊断为膝 OA 的患者进行了临床和放射学分级,并采集血液样本用于夹心 ELISA 法测定 sCOMP。45 名无骨关节炎特征的志愿者也采集了血清用于 sCOMP 测定。然后将获得的值与人口统计学指标、临床和放射学严重程度等级进行交叉参考,以评估相关性。

结果

研究组血清 COMP 明显升高(p = 0.0001)。sCOMP 的平均值和标准差分别为研究组 3400 ± 1042.9 ng/ml 和对照组 2222 ± 605.6 ng/ml。发现较高的 sCOMP 值与 OA 的较高临床和放射学等级相关。

结论

该研究表明,膝 OA 患者的 sCOMP 明显高于无该疾病的患者。sCOMP 的值也随着膝 OA 的严重程度增加而增加,表明其作为诊断和严重程度标志物的可能性。

相似文献

1
Serum cartilage oligomeric matrix protein as a biomarker for predicting development and progression of knee osteoarthritis.血清软骨寡聚基质蛋白作为预测膝关节骨关节炎发生和进展的生物标志物。
Int Orthop. 2021 Mar;45(3):551-557. doi: 10.1007/s00264-021-04943-4. Epub 2021 Jan 12.
2
Serum cartilage oligomeric matrix protein (sCOMP) is elevated in patients with knee osteoarthritis: a systematic review and meta-analysis.血清软骨寡聚基质蛋白 (sCOMP) 在膝骨关节炎患者中升高:系统评价和荟萃分析。
Osteoarthritis Cartilage. 2011 Dec;19(12):1396-404. doi: 10.1016/j.joca.2011.09.005. Epub 2011 Oct 5.
3
Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project.血清软骨寡聚基质蛋白反映骨关节炎的存在及严重程度:约翰斯顿县骨关节炎项目
Arthritis Rheum. 1999 Nov;42(11):2356-64. doi: 10.1002/1529-0131(199911)42:11<2356::AID-ANR14>3.0.CO;2-R.
4
[Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis].[软骨寡聚基质蛋白(COMP):一种非胶原蛋白软骨基质蛋白在类风湿性关节炎和骨关节炎患者中作为疾病活动和关节破坏标志物的作用]
Z Rheumatol. 1999 Apr;58(2):79-87. doi: 10.1007/s003930050156.
5
Serum cartilage oligomeric matrix protein (COMP) levels in knee osteoarthritis in a Brazilian population: clinical and radiological correlation.巴西人群膝关节骨关节炎患者血清软骨寡聚基质蛋白(COMP)水平:临床与放射学相关性研究
Scand J Rheumatol. 2007 May-Jun;36(3):211-5. doi: 10.1080/03009740601154186.
6
Serum cartilage oligomeric matrix protein (COMP) in knee osteoarthritis: a novel diagnostic and prognostic biomarker.血清软骨寡聚基质蛋白(COMP)在膝骨关节炎中的应用:一种新的诊断和预后生物标志物。
J Orthop Res. 2013 Jul;31(7):999-1006. doi: 10.1002/jor.22324. Epub 2013 Feb 19.
7
Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein.膝骨关节炎患者血清和滑液中晚期糖基化终产物戊糖苷含量增加及其与软骨寡聚基质蛋白的关系
Ann Rheum Dis. 2005 Jun;64(6):886-90. doi: 10.1136/ard.2004.029140.
8
The value of cartilage biomarkers in progressive knee osteoarthritis: cross-sectional and 6-year follow-up study in middle-aged subjects.软骨生物标志物在进展性膝骨关节炎中的价值:中年受试者的横断面和 6 年随访研究。
Rheumatol Int. 2013 Apr;33(4):903-11. doi: 10.1007/s00296-012-2463-8. Epub 2012 Jul 21.
9
Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis.血清软骨寡聚基质蛋白反映了膝关节骨关节炎患者临床诊断滑膜炎的存在。
Osteoarthritis Cartilage. 2001 Oct;9(7):612-8. doi: 10.1053/joca.2001.0434.
10
Ethnic and sex differences in serum levels of cartilage oligomeric matrix protein: the Johnston County Osteoarthritis Project.血清软骨寡聚基质蛋白水平的种族和性别差异:约翰斯顿县骨关节炎项目
Arthritis Rheum. 2003 Mar;48(3):675-81. doi: 10.1002/art.10822.

引用本文的文献

1
Protective effect of cartilage oligomeric matrix protein (COMP) on osteoarthritis-like chondrocytes based on the nuclear factor kappa B (NF-κB) pathway.基于核因子κB(NF-κB)通路的软骨寡聚基质蛋白(COMP)对骨关节炎样软骨细胞的保护作用
J Mol Histol. 2025 Aug 8;56(4):256. doi: 10.1007/s10735-025-10538-9.
2
Association of Serum Biochemical Biomarker Profiles of Joint Tissue Inflammation and Cartilage Metabolism With Posttraumatic Osteoarthritis-Related Symptoms at 12 Months After ACLR.关节组织炎症和软骨代谢的血清生化生物标志物谱与 ACLR 后 12 个月创伤后骨关节炎相关症状的相关性。
Am J Sports Med. 2024 Aug;52(10):2503-2511. doi: 10.1177/03635465241262797. Epub 2024 Aug 11.
3

本文引用的文献

1
The algofunctional indices for hip and knee osteoarthritis.髋膝关节骨关节炎的疼痛功能指标。
J Rheumatol. 1997 Apr;24(4):779-81.
Longitudinal measurement of serum cartilage oligomeric matrix protein can detect the progression of cartilage degeneration in anterior cruciate ligament reconstruction patients.
血清软骨寡聚基质蛋白的纵向测量可检测前交叉韧带重建患者软骨退变的进展。
Asia Pac J Sports Med Arthrosc Rehabil Technol. 2024 Jul 8;37:27-32. doi: 10.1016/j.asmart.2024.06.003. eCollection 2024 Jul.
4
Cartilage oligomeric matrix protein as a potential biomarker for knee osteoarthritis.软骨寡聚基质蛋白作为膝关节骨关节炎的潜在生物标志物
Bone Joint Res. 2024 Jun 1;13(6):261-271. doi: 10.1302/2046-3758.136.BJR-2023-0180.R1.
5
Diagnostic value of serum COMP and ADAMTS7 for intervertebral disc degeneration.血清 COMP 和 ADAMTS7 对椎间盘退变的诊断价值。
Eur J Med Res. 2024 Mar 25;29(1):196. doi: 10.1186/s40001-024-01784-w.
6
Delayed cartilage oligomeric matrix protein response to loading is associated with femoral cartilage composition post-ACLR.加载后软骨寡聚基质蛋白反应延迟与 ACLR 后股骨软骨成分有关。
Eur J Appl Physiol. 2023 Nov;123(11):2525-2535. doi: 10.1007/s00421-023-05253-w. Epub 2023 Jun 16.
7
Cartilage Oligomeric Matrix Protein, Diseases, and Therapeutic Opportunities.软骨寡聚基质蛋白、疾病和治疗机会。
Int J Mol Sci. 2022 Aug 17;23(16):9253. doi: 10.3390/ijms23169253.